Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Plastic

PUBLISHER: Grand View Research | PRODUCT CODE: 1571814

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1571814

Medical Grade Ultra High Molecular Weight Polyethylene Monomer Market Size, Share & Trends Analysis Report By Application (Knee Replacement, Hip Replacement), By Region, And Segment Forecasts, 2024 - 2030

PUBLISHED:
PAGES: 100 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 5950
Printable PDF (5-User License)
USD 6950
Printable PDF (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

Medical Grade Ultra High Molecular Weight Polyethylene Monomer Market Growth & Trends:

The global medical grade ultra high molecular weight polyethylene monomer market size is expected to reach USD 4.16 billion by 2030, registering a CAGR of 9.5% from 2024 to 2030, according to a new report by Grand View Research, Inc. The effectiveness of the material in medical implants due to its superior properties such as high impact strength, low reactivity, and good flexibility is expected to drive the demand over the forecast period.

UHMWPE is a material having long chains which enable it to efficiently transfer load, thus making it suitable for implantation applications. The material is extremely pliable and has good impact strength. The material has less weight as compared to metals. All these properties have increased the demand for UHMWPE for medical applications in the recent past, and this trend is expected to continue over the forecast period.

Joint replacement surgeries use ultra high molecular weight polyethylene due to its effectiveness and versatility options. There has been a surge in demand for joint replacement surgeries across the globe. Rising geriatric population, changing lifestyle and lack of fitness are the contributing factors for this trend. This trend is expected to benefit the overall demand over next eight years.

Major industry participants are trying to develop innovative implantable products which have a longer life, are more comfortable, and give a strong mechanical performance. The market is characterized by few companies occupying a dominant revenue share. Companies are taking steps to increase the product portfolio and production capacity to meet the rising demand.

Medical Grade Ultra High Molecular Weight Polyethylene Monomer Market Report Highlights:

  • Knee replacements have accounted for the dominant share of 40.9% in 2023 owing to the increasing prevalence of osteoarthritis and other joint-related conditions.
  • Total hip replacement surgeries are expected to emerge at the fastest-growing CAGR during the forecast period owing to the escalating prevalence of osteoarthritis and rheumatoid arthritis.
  • The medical grade ultra high molecular weight polyethylene monomers market in Asia Pacific registered 40.5% as the dominant market share in 2023.
  • The North America medical grade ultra high molecular weight polyethylene monomers market secured 26.0% of the market share in 2023 owing to the region's growing investment in the healthcare infrastructure.
Show more
Product Code: GVR-1-68038-272-3

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million) (Volume in Kilotons)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market: Application Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market: Application Movement Analysis, USD Million, Volume in Kilotons, 2023 & 2030
  • 4.3. Total Hip Replacement
    • 4.3.1. Total Hip Replacement Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
  • 4.4. Knee Replacement
    • 4.4.1. Knee Replacement Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
  • 4.5. Shoulder Replacement
    • 4.5.1. Shoulder Replacement Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
  • 4.6. Ankle Replacement
    • 4.6.1. Ankle Replacement Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
  • 4.7. Small Joints
    • 4.7.1. Small Joints Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)

Chapter 5. Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market: Regional Estimates & Trend Analysis

  • 5.1. Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer tMarket Share, By Region, 2023 & 2030, USD Million, Volume in Kilotons
  • 5.2. North America
    • 5.2.1. North America Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.2.2. U.S.
      • 5.2.2.1. U.S. Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.2.3. Canada
      • 5.2.3.1. Canada Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.2.4. Mexico
      • 5.2.4.1. Mexico Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
  • 5.3. Europe
    • 5.3.1. Europe Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.3.2. U.K.
      • 5.3.2.1. U.K. Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.3.3. Germany
      • 5.3.3.1. Germany Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.3.4. France
      • 5.3.4.1. France Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.3.5. Italy
      • 5.3.5.1. Italy Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.3.6. Spain
      • 5.3.6.1. Spain Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.3.7. Russia
      • 5.3.7.1. Russia Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.3.8. Demark
      • 5.3.8.1. Denmark Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.3.9. Sweden
      • 5.3.9.1. Sweden Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.3.10. Norway
      • 5.3.10.1. Norway Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
  • 5.4. Asia Pacific
    • 5.4.1. Asia Pacific Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.4.2. China
      • 5.4.2.1. China Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.4.3. Japan
      • 5.4.3.1. Japan Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.4.4. India
      • 5.4.4.1. India Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.4.5. Australia
      • 5.4.5.1. Australia Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.4.6. South Korea
      • 5.4.6.1. South Korea Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.4.7. Indonesia
      • 5.4.7.1. Indonesia Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.4.8. Vietnam
      • 5.4.8.1. Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
  • 5.5. Latin America
    • 5.5.1. Latin America Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.5.2. Brazil
      • 5.5.2.1. Brazil Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.5.3. Argentina
      • 5.5.3.1. Argentina Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
  • 5.6. Middle East and Africa
    • 5.6.1. Middle East and Africa Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.2. Saudi Arabia
      • 5.6.2.1. Saudi Arabia Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.6.3. South Africa
      • 5.6.3.1. South Africa Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.6.4. UAE
      • 5.6.4.1. UAE Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.6.5. Kuwait
      • 5.6.5.1. Kuwait Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis by Key Market Participants
  • 6.2. Company Categorization
  • 6.3. Company Heat Map Analysis
  • 6.4. Company Profiles
    • 6.4.1. Celanese Corporation
      • 6.4.1.1. Participant's Overview
      • 6.4.1.2. Financial Performance
      • 6.4.1.3. Product Benchmarking
      • 6.4.1.4. Recent Developments/ Strategic Initiatives
    • 6.4.2. DSM Biomedical
      • 6.4.2.1. Participant's Overview
      • 6.4.2.2. Financial Performance
      • 6.4.2.3. Product Benchmarking
      • 6.4.2.4. Recent Developments/ Strategic Initiatives
    • 6.4.3. Honeywell International Inc.
      • 6.4.3.1. Participant's Overview
      • 6.4.3.2. Financial Performance
      • 6.4.3.3. Product Benchmarking
      • 6.4.3.4. Recent Developments/ Strategic Initiatives
    • 6.4.4. Mitsui Chemicals, Inc.
      • 6.4.4.1. Participant's Overview
      • 6.4.4.2. Financial Performance
      • 6.4.4.3. Product Benchmarking
      • 6.4.4.4. Recent Developments/ Strategic Initiatives
    • 6.4.5. TEIJIN LIMITED
      • 6.4.5.1. Participant's Overview
      • 6.4.5.2. Financial Performance
      • 6.4.5.3. Product Benchmarking
      • 6.4.5.4. Recent Developments/ Strategic Initiatives
    • 6.4.6. LyondellBasell Industries Holdings B.V.
      • 6.4.6.1. Participant's Overview
      • 6.4.6.2. Financial Performance
      • 6.4.6.3. Product Benchmarking
      • 6.4.6.4. Recent Developments/ Strategic Initiatives
    • 6.4.7. Orthoplastics Ltd.
      • 6.4.7.1. Participant's Overview
      • 6.4.7.2. Financial Performance
      • 6.4.7.3. Product Benchmarking
      • 6.4.7.4. Recent Developments/ Strategic Initiatives
    • 6.4.8. Tianyi Biomedical Technology Co., Ltd.
      • 6.4.8.1. Participant's Overview
      • 6.4.8.2. Financial Performance
      • 6.4.8.3. Product Benchmarking
      • 6.4.8.4. Recent Developments/ Strategic Initiatives
    • 6.4.9. Quadrant Engineering Plastic Products (Mitsubishi Chemical Advanced Materials)
      • 6.4.9.1. Participant's Overview
      • 6.4.9.2. Financial Performance
      • 6.4.9.3. Product Benchmarking
      • 6.4.9.4. Recent Developments/ Strategic Initiatives
    • 6.4.10. Asahi Kasei Corporation
      • 6.4.10.1. Participant's Overview
      • 6.4.10.2. Financial Performance
      • 6.4.10.3. Product Benchmarking
      • 6.4.10.4. Recent Developments/ Strategic Initiatives
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!